ResearcherLanzhou University Second HospitalActive in the last 2 years
Xiangyan Jiang
Matched on ORCID iD 0000-0002-2685-2899; OpenAlex author ID A5053164286. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 3 papers
Papers 9
- UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer. Co-author DOI 10.1002/advs.202514933↗
- USP20 promotes CD8+ T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2026-338277↗
- USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1228↗
- A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic cancer therapy efficiency. Co-author DOI 10.1016/j.mtbio.2025.101463↗
- KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. Co-author DOI 10.1016/j.xcrm.2025.101966↗
- Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress. Co-author DOI 10.1053/j.gastro.2023.02.025↗
- Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08769-6↗
- Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-148631/v1↗
- Comprehensive Analysis of the Transcriptional Expressions and Prognostic Value of S100A Family in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-149466/v1↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zuoyi Jiao · 6 shared papers, 2023–2026 · strength 1.25
- Paper UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition … DOI 10.1002/advs.202514933↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Paper USP20 promotes CD8+ T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism … DOI 10.1136/gutjnl-2026-338277↗
- Zeyuan Yu · 7 shared papers, 2021–2026 · strength 1.21
- Paper UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition … DOI 10.1002/advs.202514933↗
- Paper USP20 promotes CD8+ T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism … DOI 10.1136/gutjnl-2026-338277↗
- Paper KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for … DOI 10.1016/j.xcrm.2025.101966↗
- Yong Ma · 5 shared papers, 2021–2026 · strength 0.97
- Paper UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition … DOI 10.1002/advs.202514933↗
- Paper USP20 promotes CD8+ T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism … DOI 10.1136/gutjnl-2026-338277↗
- Paper USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Ca… DOI 10.1158/0008-5472.can-25-1228↗
- Yuman Dong · 3 shared papers, 2025–2026 · strength 0.63
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Paper USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Ca… DOI 10.1158/0008-5472.can-25-1228↗
- Paper KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for … DOI 10.1016/j.xcrm.2025.101966↗
- Hongbin Li · 3 shared papers, 2021 · strength 0.41
- Paper Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal ade… DOI 10.21203/rs.3.rs-148631/v1↗
- Paper Comprehensive Analysis of the Transcriptional Expressions and Prognostic Value of S100A Family in Pancreatic Ductal Ade… DOI 10.21203/rs.3.rs-149466/v1↗
- Paper Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal ade… DOI 10.1186/s12885-021-08769-6↗
- Tao Wang · 2 shared papers, 2023–2025 · strength 0.33
- Paper KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for … DOI 10.1016/j.xcrm.2025.101966↗
- Paper Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replicati… DOI 10.1053/j.gastro.2023.02.025↗
- Junhong Guan · 2 shared papers, 2023–2025 · strength 0.33
- Paper KRAS G12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for … DOI 10.1016/j.xcrm.2025.101966↗
- Paper Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replicati… DOI 10.1053/j.gastro.2023.02.025↗
- Jieru Li · 1 shared paper, 2025 · strength 0.23
- Yiwei Dai · 1 shared paper, 2025 · strength 0.23
- Rufu Chen · 1 shared paper, 2026 · strength 0.23
- Lei Zhao · 1 shared paper, 2021 · strength 0.14
- Леи Жао · 1 shared paper, 2021 · strength 0.14
- Yong Ma · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.